Many professionals in the life sciences industry are excited about the benefits decentralized clinical trials (DCTs) bring to the clinical research process and specifically to patients. The use of wearables, electronic consent forms, digital outcomes assessments, and other DCT technologies are transforming how we gather clinical data and interact with study participants.
However, amidst all the excitement about what the technology can do, it is easy to forget about the risks. Every time a sponsor or site adds a new technology to the DCT environment, they must be certain that the data they collect, clean, and/or analyze is protected at every step in its journey.
